SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
42.99 EUR
-0.81 (-1.85%)
Taking everything into account, SHL scores 5 out of 10 in our fundamental rating. SHL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
Each year in the past 5 years SHL has been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.83%, SHL is doing good in the industry, outperforming 63.49% of the companies in the same industry.
SHL has a Return On Equity of 11.88%. This is in the better half of the industry: SHL outperforms 66.67% of its industry peers.
The Return On Invested Capital of SHL (7.65%) is better than 61.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.81%.
The last Return On Invested Capital (7.65%) for SHL is above the 3 year average (6.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.65% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
Looking at the Profit Margin, with a value of 9.17%, SHL is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
In the last couple of years the Profit Margin of SHL has remained more or less at the same level.
The Operating Margin of SHL (13.53%) is better than 61.90% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
SHL's Gross Margin of 38.63% is on the low side compared to the rest of the industry. SHL is outperformed by 79.37% of its industry peers.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SHL has more shares outstanding
SHL has more shares outstanding than it did 5 years ago.
SHL has a better debt/assets ratio than last year.
2.2 Solvency
SHL has an Altman-Z score of 2.03. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 2.03 is in line compared to the rest of the industry. SHL outperforms 44.44% of its industry peers.
SHL has a debt to FCF ratio of 5.45. This is a neutral value as SHL would need 5.45 years to pay back of all of its debts.
SHL has a Debt to FCF ratio (5.45) which is in line with its industry peers.
SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating SHL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, SHL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 2.03 |
ROIC/WACC1.23
WACC6.24%
2.3 Liquidity
SHL has a Current Ratio of 1.11. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL has a worse Current ratio (1.11) than 71.43% of its industry peers.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, SHL is not doing good in the industry: 73.02% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.17% over the past year.
The Earnings Per Share has been growing by 11.29% on average over the past years. This is quite good.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.79% on average per year.
The Revenue is expected to grow by 5.85% on average over the next years.
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.99, SHL is valued on the expensive side.
Based on the Price/Earnings ratio, SHL is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
SHL is valuated rather cheaply when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
SHL is valuated rather expensively with a Price/Forward Earnings ratio of 17.67.
SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 63.49% of the companies in the same industry.
SHL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.99 | ||
| Fwd PE | 17.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 65.08% of the companies are valued more expensively.
SHL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SHL is cheaper than 84.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.87 | ||
| EV/EBITDA | 13.76 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)10.12
PEG (5Y)1.59
EPS Next 2Y6.58%
EPS Next 3Y8.95%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.34%. Purely for dividend investing, there may be better candidates out there.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.14. SHL pays more dividend than 84.13% of the companies in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.34% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 49.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.72%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
FRA:SHL (12/10/2025, 7:00:00 PM)
42.99
-0.81 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.49B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts80
Price Target56.9 (32.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.34% |
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-6.13%
PT rev (3m)-8.05%
EPS NQ rev (1m)-8.32%
EPS NQ rev (3m)-8.32%
EPS NY rev (1m)-4.69%
EPS NY rev (3m)-7.09%
Revenue NQ rev (1m)1.66%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-1.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.99 | ||
| Fwd PE | 17.67 | ||
| P/S | 2.07 | ||
| P/FCF | 17.87 | ||
| P/OCF | 13.73 | ||
| P/B | 2.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.76 |
EPS(TTM)2.39
EY5.56%
EPS(NY)2.43
Fwd EY5.66%
FCF(TTM)2.41
FCFY5.6%
OCF(TTM)3.13
OCFY7.28%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)10.12
PEG (5Y)1.59
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.65% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 43.54% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.23% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.03 |
F-Score8
WACC6.24%
ROIC/WACC1.23
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year35.66%
EBIT Next 3Y17.7%
EBIT Next 5Y14.23%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 17.99 and the Price/Book (PB) ratio is 2.69.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.